@kdjhaveri

http://twitter.com/kdjhaveri

2024 Jan @KidneyNews https://bit.ly/3vp5P2v @PaulHannaMD @gudnephron Emerging Trends in Onconephrology: 2024 Edition-- what we learnt @ASNKidney #kidneywk 2023 https://bit.ly/48EKYGz

— Kenar Jhaveri (@kdjhaveri) Jan 3, 2024

https://twitter.com/kdjhaveri/status/1742652585520124288

@NephRodby

http://twitter.com/NephRodby

@VelezNephHepato @rmohty The #KidneyWk post lecture Q&A was nothing but calm! https://bit.ly/3GT2lHN

— Roger Rodby (@NephRodby) Dec 23, 2023

https://twitter.com/NephRodby/status/1738355430621876499

@hswapnil

http://twitter.com/hswapnil

via @brian_rifkin - slow or fast for hyponatremia correction? - AFib and anticoagulation (Renal AF, AXADIA published, SAFE-D at #kidneywk) #TopNephrology nominations

— Swapnil Hiremath @hswapnil@med-mastodon.com (@hswapnil) Dec 21, 2023

https://twitter.com/hswapnil/status/1737913741864292412

@rheault_m

http://twitter.com/rheault_m

@hswapnil ✅ FDA Approval of new drugs for IgA nephropathy ✅Nephrology match results for peds and adult remain concerning. ✅ERA elects its first woman president. The last of the major nephrology societies to do so. ✅#NephJC podcast recording at #KidneyWk #TopNephrology

— Michelle Rheault (@rheault_m) Dec 21, 2023

https://twitter.com/rheault_m/status/1737904123956330745

@hswapnil

http://twitter.com/hswapnil

I will start with: - Renal denervation finally approved in the USA (both Medtronic and Otsuka/ReCor) - Endothelin antagonists advance (PROTECT/DUPLEX/PRECISION/ZENITH) - Inaxaplin in APOL1 - Freely Filtered simul-broadcast with @AmitXGarg #KidneyWk #TopNephrology nominations

— Swapnil Hiremath @hswapnil@med-mastodon.com (@hswapnil) Dec 21, 2023

https://twitter.com/hswapnil/status/1737886439335927980

@ASNKidney

http://twitter.com/ASNKidney

Have you claimed your CE credits and MOC points for participating in #KidneyWk? Log in to the ASN eLearning Center now to complete the process. ⚠️ The deadline is today, Wednesday, December 20. ⚠️ Get Started: https://bit.ly/4762YIT https://bit.ly/488Fkgi

— American Society of Nephrology (@ASNKidney) Dec 20, 2023

https://twitter.com/ASNKidney/status/1737473237963989122

@JAMAInternalMed

http://twitter.com/JAMAInternalMed

Among transplant-eligible pts w/ advanced chronic kidney disease, this multicomponent intervention, which targeted many barriers to receiving a kidney transplant, did not significantly increase overall access to kidney transplantation. #KidneyWk @ASNKidney https://bit.ly/3vgeDYb

— JAMA Internal Medicine (@JAMAInternalMed) Dec 20, 2023

https://twitter.com/JAMAInternalMed/status/1737427627709718924

@ASNKidney

http://twitter.com/ASNKidney

🚨 Deadline Tomorrow 🚨 Only one day left to claim your CE credits and MOC points for participating in #KidneyWk before the deadline on Wednesday, December 20. Log in to the ASN eLearning Center today to get started. Log in: https://bit.ly/4762YIT https://bit.ly/3v7kwXI

— American Society of Nephrology (@ASNKidney) Dec 19, 2023

https://twitter.com/ASNKidney/status/1737201339212423192

@kidney_boy

http://twitter.com/kidney_boy

At this year's @ASNKidney #KidneyWk there was a RCT of reactive ddavp versus proactive DDAVP (DDAVP Clamp) in severe hyponatremia If you went to Kidney Week you can see the presentation here: https://bit.ly/41sO3Hl https://bit.ly/471Ei4m

— Joel M. Topf, MD FACP (@kidney_boy) Dec 17, 2023

https://twitter.com/kidney_boy/status/1736447293962797304

@ASNKidney

http://twitter.com/ASNKidney

Stay on top of the latest trends and advancements in nephrology with Kidney Week On-Demand. Access over 200 hours of educational content presented during ASN #KidneyWk 2023, including Early Program and Annual Meeting sessions. Get Started: https://bit.ly/4aivvh8 https://bit.ly/488tbrc

— American Society of Nephrology (@ASNKidney) Dec 14, 2023

https://twitter.com/ASNKidney/status/1735329111680106760